Work

Abstract A070: Optimal efficacious dose prediction of a novel protein degrader ASP3082 selectively targeting KRAS G12D using quantitative systems pharmacology

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-a070

Authors: Pouye Sedighian, Stanley C. Gill, Junko Toyoshima, Yoshihiro Nishizono, Mamoru Tasaki, Kanako Iguchi, Yosuke Yamanaka, Peter Bonate

Institutions: Astellas Pharma (United States), Astellas Pharma (Japan)

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415444414

Cites:

Cited by: 1

Related to: